Letter to the EditorPolygenetic components for schizophrenia, bipolar disorder and rheumatoid arthritis predict risk of schizophrenia
Section snippets
Role of funding source
This work was supported by research grants from the Japanese Ministry of Health, Labor and Welfare (H22-seishin-ippan-001), KAKENHI, a 22390225-Grant-in-Aid for Scientific Research (B), a 23659565-Grant-in-Aid for Challenging Exploratory Research and a Grant-in-Aid for Scientific Research on Innovative Areas (Comprehensive Brain Science Network) from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) and the Japan Foundation for Neuroscience and Mental Health.
Contributors
K. Ohi was critically involved in the design, performed the analysis and interpretation of the data and wrote the manuscript. R. Hashimoto supervised the entire project, was critically involved in the design, analysis and interpretation of the data and was responsible for performing the literature review. M. Kikuchi, M. Ikeda, H. Yamamori, Y. Yasuda, M. Fujimoto, H. Fujino, K. Miura, M. Fukunaga, A. Nakaya, and N. Iwata were involved in the subject recruitment and the clinical diagnostic
Conflict of interest
All authors declare that they have no conflicts of interest.
Acknowledgements
We would like to thank all of the individuals who participated in this study.
References (11)
Power and predictive accuracy of polygenic risk scores
PLoS Genet.
(2013)- et al.
The relationship between schizophrenia and rheumatoid arthritis revisited: genetic and epidemiological analyses
Am. J. Med. Genet. B Neuropsychiatr. Genet.
(2015) - et al.
New data and an old puzzle: the negative association between schizophrenia and rheumatoid arthritis
Int. J. Epidemiol.
(2015) - et al.
Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations
Nat. Genet.
(2015) - et al.
Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility
Nat. Genet.
(2014)
Cited by (15)
Intelligence decline between present and premorbid IQ in schizophrenia: Schizophrenia Non-Affected Relative Project (SNARP)
2019, European NeuropsychopharmacologyCitation Excerpt :The NART is a test that was developed to estimate premorbid IQ because reading ability is relatively intact in SCZ patients (Dalby and Williams, 1986), and its validity has been confirmed in English-speaking SCZ patients (Amminger et al., 2002; Badcock et al., 2005; Schretlen et al., 2007). The Japanese version of the NART (JART, Matsuoka et al., 2006) is widely used to estimate premorbid IQ in Japanese-speaking patients, as an equivalent to the NART (Ohi et al., 2013a, 2013b, 2014, 2015, 2016a, 2016c, 2017a). To measure the premorbid IQ, we administered the JART.
Polygenic Risk Scores Differentiating Schizophrenia from Bipolar Disorder Are Associated with Premorbid Intelligence in Schizophrenia Patients and Healthy Subjects
2021, International Journal of NeuropsychopharmacologyEffects of age and sex on eye movement characteristics
2021, Neuropsychopharmacology Reports